Browsing: Granules India

5 months ago

5 months ago Granules India receives FDA approval for Lisdexamfetamine Dimesylate capsules for treatment of ADHD

5 months ago Granules India Voluntarily Halts Production at Gagillapur Plant Following US FDA Observations

6 months ago

6 months ago Granules India Ltd: Block Trade Indicates Institutional Interest

7 months ago

7 months ago Granules India Receives FDA Approval for ADHD Drug Amidst US Shortages

7 months ago Granules India Responds to US FDA Observations

7 months ago Granules India’s Net-Zero Commitment Validated by SBTi

8 months ago

8 months ago Granules India’s Unit V Facility Receives Positive US FDA Inspection

9 months ago

9 months ago Granules India Secures US FDA Approval for Bupropion Hydrochloride Extended-Release Tablets